miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Gut

• Publication date

  2014-10-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/gutjnl-2014-307980PMID 25281418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The activation and regulation of IL-17 receptor mediated signaling.

  2013cited by this paper
• Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation

  2013cited by this paper
• IL-25 Downregulates Th1/Th17 Immune Response in an IL-10–Dependent Manner in Inflammatory Bowel Disease

  2013cited by this paper
• Microbiota regulation of inflammatory bowel disease and colorectal cancer.

  2013cited by this paper
• MicroRNA‐146b improves intestinal injury in mouse colitis by activating nuclear factor‐κB and improving epithelial barrier function

  2013cited by this paper
• Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome

  2013cited by this paper
• miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease

  2013cited by this paper
• TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells

  2012cited by this paper
• Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

  2012cited by this paper
• MicroRNAs in inflammatory bowel disease

  2012cited by this paper
• Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

  2012cited by this paper
• microRNA regulation of inflammatory responses.

  2012cited by this paper
• MicroRNA 10a Marks Regulatory T Cells

  2012cited by this paper
• Functional polymorphism in IL12B promoter site is associated with ulcerative colitis.

  2011cited by this paper
• MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathway

  2011cited by this paper
• Microbiota Downregulates Dendritic Cell Expression of miR-10a, Which Targets IL-12/IL-23p40

  2011cited by this paper
• The increased expression of IL‐23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity

  2011cited by this paper
• Interleukin (IL)-23 Suppresses IL-10 in Inflammatory Bowel Disease*

  2011cited by this paper
• Intestinal homeostasis and its breakdown in inflammatory bowel disease

  2011cited by this paper
• Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.

  2010cited by this paper
• MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro

  2010cited by this paper
• Identification of microRNAs associated with ileal and colonic Crohn's disease†

  2010cited by this paper
• MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development.

  2010cited by this paper
• An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a

  2009cited by this paper
• NOD2 Ligation Subverts IFN-α Production by Liver Plasmacytoid Dendritic Cells and Inhibits Their T Cell Allostimulatory Activity via B7-H1 Up-Regulation1

  2009cited by this paper
• A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation

  2008cited by this paper
• Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

  2008cited by this paper
• A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.

  2008cited by this paper
• A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

  2008cited by this paper
• Intracellular NOD-like receptors in host defense and disease.

  2007cited by this paper
• Regulation of the Germinal Center Response by MicroRNA-155

  2007cited by this paper
• Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

  2007cited by this paper
• Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

  2006cited by this paper
• Differential Pattern Recognition Receptor Expression but Stereotyped Responsiveness in Rat Spleen Dendritic Cell Subsets1

  2006cited by this paper
• NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

  2006cited by this paper
• Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota

  2005cited by this paper
• Inflammatory diseases: is ubiquitinated NEMO at the hub?

  2004cited by this paper
• NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

  2004cited by this paper
• MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression

  2004cited by this paper
• NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality.

  2004cited by this paper
• The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.

  2004cited by this paper
• NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses

  2004cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper

• Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives

  2026cites this paper
• MicroRNA-microbiome cross-kingdom networks drive inflammatory bowel disease through dynamic regulatory ecosystems (Review)

  2026cites this paper
• MicroRNA‐microbiota interactions: Emerging strategies for modulating intestinal homeostasis and enhancing host health

  2025cites this paper
• Bidirectional Interplay Among Non-Coding RNAs, the Microbiome, and the Host During Development and Diseases

  2025cites this paper
• Analysis of miR‐10a and IFNG Expression Before and After Treatment for Chronic Schistosomiasis mansoni

  2025cites this paper
• Relief of EGFR/FOS-downregulated miR-103a by loganin alleviates NF-kappaB-triggered inflammation and gut barrier disruption in colitis

  2025cites this paper
• Role of Pyroptosis in inflammatory bowel disease.

  2025cites this paper
• Therapeutic potential of miR-10a overexpressing mesenchymal stem cell–derived extracellular vesicles in modulating inflammation in collagen-induced arthritis

  2025cites this paper
• The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity

  2024influential citation
• The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases

  2024cites this paper
• Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients

  2024cites this paper
• Apoptosis of Dendritic Cells and Autoimmune Disease.

  2024cites this paper
• Epigenetic Mechanisms of Genes Influencing Immune Response in Patients with Celiac Disease

  2024cites this paper
• An altered expression of miR‐376a‐3p and miR‐20a‐5p in peripheral blood exosomes regulates the autophagy and inflammatory systemic substrates, and relates to the smoking habit and age in Crohn's disease

  2024cites this paper
• Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review)

  2024cites this paper
• Innate immune cells in the pathogenesis of inflammatory bowel disease - from microbial metabolites to immune modulation

  2024cites this paper
• Altered miR-10a gene expression in peripheral blood mononuclear cells correlates with frequency of T regulatory cells and cytokine profile in multiple sclerosis patients.

  2024cites this paper
• Role of microRNAs in the crosstalk between the gut microbiota and intestinal immune system

  2023cites this paper
• Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics.

  2023cites this paper
• PTK2B regulates immune responses of neutrophils and protects mucosal inflammation in ulcerative colitis

  2023cites this paper
• miR-10a-3p modulates adiposity and suppresses adipose inflammation through TGF-β1/Smad3 signaling pathway

  2023cites this paper
• Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future

  2023cites this paper
• Integrated Analysis of Ulcerative Colitis Revealed an Association between PHLPP2 and Immune Infiltration

  2022cites this paper
• The Role of microRNAs in Inflammation

  2022cites this paper
• The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease.

  2022cites this paper
• Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases

  2022cites this paper
• Postbiotics and Their Health Modulatory Biomolecules

  2022cites this paper
• Deficiency of microRNA-10b promotes DSS-induced inflammatory response via impairing intestinal barrier function.

  2022cites this paper
• RNA-Seq Approach to Investigate the Effects of Melatonin on Bone Marrow-Derived Dendritic Cells from Dextran Sodium Sulfate-Induced Colitis Mice.

  2022cites this paper
• Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease

  2022cites this paper
• miRNA effects on gut homeostasis: therapeutic implications for inflammatory bowel disease.

  2022cites this paper
• Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease

  2022cites this paper
• The involvement of TH17 cells in the pathogenesis of IBD.

  2022cites this paper
• Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models

  2022cites this paper
• The functional role of miRNAs in inflammatory pathways associated with intestinal epithelial tight junction barrier regulation in IBD

  2022cites this paper
• EpisomiR, a New Family of miRNAs, and Its Possible Roles in Human Diseases

  2022cites this paper
• Role, Significance, and Association of MicroRNA-10a/b in Physiology of Cancer.

  2022cites this paper
• Non-coding RNAs in Neonatal Necrotizing Enterocolitis

  2022cites this paper
• Clinical Significance of Novel Neutrophil-Based Biomarkers in the Diagnosis and Prediction of Response to Infliximab Therapy in Crohn’s Disease

  2022cites this paper
• MicroRNA-5112 Targets IKKγ to Dampen the Inflammatory Response and Improve Clinical Symptoms in Both Bacterial Infection and DSS-Induced Colitis

  2022cites this paper
• The impact of MicroRNAs in Neonatal Necrotizing Enterocolitis & other inflammatory conditions of intestine.

  2022cites this paper
• SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner

  2022cites this paper
• miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases

  2021cites this paper
• MicroRNA‐590‐3p inhibits T helper 17 cells and ameliorates inflammation in lupus mice

  2021cites this paper
• MicroRNA-497 inhibits inflammation in DSS-induced IBD model mice and lipopolysaccharide-induced RAW264.7 cells via Wnt/β-catenin pathway.

  2021cites this paper
• Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.

  2021cites this paper
• Dendrobium officinale Polysaccharide Alleviates Intestinal Inflammation by Promoting Small Extracellular Vesicle Packaging of miR-433-3p.

  2021cites this paper
• Chemical compositions, anti-oxidant and anti-inflammatory potential of ethanol extract from Zhuke-Hulu tea

  2021cites this paper
• MicroRNA expression in inflammatory bowel disease-associated colorectal cancer

  2021cites this paper
• Mir-142-3p Regulates Inflammatory Response by Contributing to Increased TNF-α in Chronic Rhinosinusitis With Nasal Polyposis

  2021cites this paper
• Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models

  2021cites this paper
• Berberine combined with stachyose improves glycometabolism and gut microbiota through regulating colonic microRNA and gene expression in diabetic rats.

  2021cites this paper
• Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosomes-packaged miR-149-3p.

  2021cites this paper
• Immunomodulatory Role and Therapeutic Potential of Non-Coding RNAs Mediated by Dendritic Cells in Autoimmune and Immune Tolerance-Related Diseases

  2021cites this paper
• MicroRNA-10a Negatively Regulates CD4+ T Cell IL-10 Production through Suppression of Blimp1

  2021cites this paper
• Increased miR-6875-5p inhibits plasmacytoid dendritic cell differentiation via the STAT3/E2-2 pathway in recurrent spontaneous abortion

  2021cites this paper
• Roles of microRNAs in inflammatory bowel disease

  2021cites this paper
• NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells

  2021cites this paper
• Cell-to-Cell Communication by Host-Released Extracellular Vesicles in the Gut: Implications in Health and Disease

  2021cites this paper
• Roles of Macrophages in the Development and Treatment of Gut Inflammation

  2021cites this paper
• CircRNA_103765 acts as a proinflammatory factor via sponging miR-30 family in Crohn’s disease

  2021cites this paper
• Tripterygium wilfordii Polyglycoside Ameliorated TNBS-Induced Colitis in Rats via Regulating Th17/Treg Balance in Intestinal Mucosa

  2021influential citation
• IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases.

  2020cites this paper
• CD4+ T-Cell Differentiation In Vitro.

  2020cites this paper
• Role of Host and Pathogen-Derived MicroRNAs in Immune Regulation During Infectious and Inflammatory Diseases

  2020cites this paper
• Downregulation of LncRNA OIP5-AS1 Induced by IL-1β Aggravates Osteoarthritis via Regulating miR-29b-3p/PGRN

  2020cites this paper
• miR-10a in Peripheral Blood Mononuclear Cells Is a Biomarker for Sepsis and Has Anti-Inflammatory Function

  2020cites this paper
• Role of microRNAs in the Regulation of Dendritic Cell Generation and Function

  2020cites this paper
• Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease

  2020cites this paper
• Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers

  2020cites this paper
• Identification of microRNAs involved in NOD-dependent induction of pro-inflammatory genes in pulmonary endothelial cells

  2020cites this paper
• Dietary intake of Lycium ruthenicum Murray ethanol extract inhibits colonic inflammation in dextran sulfate sodium-induced murine experimental colitis.

  2020cites this paper
• microRNA in inflammatory bowel disease at a glance.

  2020cites this paper
• MiR-1-3p facilitates Th17 differentiation associating with multiple sclerosis via targeting ETS1.

  2020cites this paper
• Dendritic cell biology and its role in tumor immunotherapy

  2020cites this paper
• The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease.

  2020cites this paper
• TL1A primed dendritic cells activation exacerbated chronic murine colitis.

  2020cites this paper
• Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4+ T cell.

  2020cites this paper
• MicroRNA-10a-3p mediates Th17/Treg cell balance and improves renal injury by inhibiting REG3A in lupus nephritis.

  2020cites this paper
• MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review

  2020cites this paper
• MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer

  2020cites this paper
• Epigenetic mechanisms in the regulation of lymphocyte differentiation

  2020cites this paper
• Nrf2-induced miR-23a-27a-24-2 cluster modulates damage repair of intestinal mucosa by targeting the Bach1/HO-1 axis in inflammatory bowel diseases.

  2020cites this paper
• Angelica polysaccharide mitigates lipopolysaccharide-evoked inflammatory injury by regulating microRNA-10a in neuronal cell line HT22

  2019cites this paper
• MicroRNAs and Inflammatory Bowel Disease

  2019cites this paper
• MicroRNA determines the fate of intestinal epithelial cell differentiation and regulates intestinal diseases.

  2019cites this paper
• MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome.

  2019cites this paper
• miRNAs and Their Role in the Pathogenesis of Celiac Disease: A Review

  2019cites this paper
• MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases.

  2019cites this paper
• miRNAs as Therapeutic Targets in Inflammatory Disease.

  2019cites this paper
• MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease

  2019cites this paper
• The Role of Adaptor Protein CARD9 in Colitis-Associated Cancer

  2019cites this paper
• MicroRNAs, intestinal inflammatory and tumor.

  2019cites this paper
• Feruloylated Oligosaccharides Alleviates Dextran Sulphate Sodium-Induced Colitis in vivo.

  2019cites this paper
• Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.

  2018cites this paper
• Intestinal Dendritic Cells in Health and Gut Inflammation

  2018cites this paper
• MiRNAs and inflammatory bowel disease: An interesting new story

  2018cites this paper
• Exopolysaccharides from Lactobacillus plantarum NCU116 Regulate Intestinal Barrier Function via STAT3 Signaling Pathway.

  2018cites this paper
• The MicroRNA‐326: Autoimmune diseases, diagnostic biomarker, and therapeutic target

  2018cites this paper
• Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

  2018cites this paper